Upload
phamkhuong
View
213
Download
0
Embed Size (px)
Citation preview
Research & Development 2 2014 World leader in gases, technologies and services for Industry and Health
How to address these challenges?
210M chronic obstructive pulmonary disease (COPD) patients worldwide
in 2050 solar electricity will contribute 25% to global electricity production
50bn connected devices in 2020
100 million people will die between 2002 to 2020 from water-related disease
by 2030 60% of the world’s population will be urban
By 2030 urban areas will account for 75% CO2 emissions
2030: Transport accounts for 1/3 of EU-25 energy demand
Research & Development 3 2014 World leader in gases, technologies and services for Industry and Health
… WITH A UNIQUE VANTAGE POINT
PHOTOVOLTAICS
Air Liquide as a solution provider
TECHNOLOGIES
STEELMAKING
FOOD
HEALTH
H2 MOBILITY
EXPLORING & PETROCHEMICALS
ELECTRONICS
AUTOMOTIVE
GLASS
… CONTRIBUTING TO MULTIPLE SECTORS
HYDROGEN
CARBON MONOXIDE
ARGON
OXYGEN NITROGEN
SILANE
HELIUM
ACETYLEN
CARBON DIOXIDE
Research & Development 4 2014 World leader in gases, technologies and services for Industry and Health
R&D SOCIETAL FOCUS
THREE MAJOR TRENDS
INDUSTRY GLOBALIZATION
& RESOURCE CONSTRAINTS
EVOLVING CONSUMPTION
& DEMOGRAPHICS APPETITE
FOR INNOVATION
ENERGY DEMAND
BIO-ECONOMY & ECO-DESIGN
HEALTH & WELLNESS
DIGITAL & DIRECT
LOCAL INNOVATION
R&D opening new ways
Research & Development 5 2014 World leader in gases, technologies and services for Industry and Health
From an early start-up to a world leader
1902 - Georges Claude and Paul Delorme developed an energy efficient process to liquefy air and produce oxygen
For the last 110 years - Air Liquide innovates to become world leader in gases, technologies and services for Industry and Health
Driven by the spirit of innovation
Research & Development 7 2014 World leader in gases, technologies and services for Industry and Health
Key figures
10 R&D locations
3 continents
1100 researchers 35 nationalities
321 new patents
265 Million € innovation budget
* 2013 key figures
Research & Development 8 2014 World leader in gases, technologies and services for Industry and Health
A global R&D network
Shanghai R&T (China) ALL (Japan) ALLK (South Korea) DRTC (Delaware)
Group R&D R&D Subsidiaries
Paris-Saclay Research Center CTAS
SEPPIC Air Liquide Medical Systems
FRTC (Frankfurt) Schülke
France
Germany
United States
Asia
Research & Development 9 2014 World leader in gases, technologies and services for Industry and Health
Engaging in the innovation ecosystem worldwide…
Seattle
San Francisco Silicon Valley
Los Angeles
Toronto
Chicago Boston
London
Stockholm
Skolkovo
Paris-Saclay
Abu Dhabi Masdar City Bangalore
Singapore
Beijing
Tel Aviv Dubai
Zurich Munich
Mexico City
Bogotá
Quito
Santiago
Brasilia
São Paulo Rio de Janeiro
Curitiba
Buenos Aires Montevideo
Montréal
New York Philadelphia - Wilmington
Atlanta
Geneva
Stuttgart Frankfurt
Berlin
Helsinki
Jerusalem
Johannesburg
Cape Town
Doha Edu City
New Delhi Shanghai
Taipei
Seoul Tokyo – Tsukuba Yokohama
Osaka Kobe
Nagoya
KAUST
Air Liquide strategic partners
Clusters
South America
Whole New World
Asia - Pacific
North America Europe
Research & Development 10 2014 World leader in gases, technologies and services for Industry and Health
…through our stakeholders
ANR = The French National Research Agency EEC = European Economic Community DOE = U.S. Department of Energy
Research & Development 11 2014 World leader in gases, technologies and services for Industry and Health
Group R&D Purpose
Creating sustainable value for Air Liquide and its customers by exploring new technological territories to address the challenges facing Society.
As a spearhead for innovation, R&D plays a major role in:
Delivering competitive technologies to grow core business
Reaching excellence through scientific know-how and expertise
Exploring new territories to identify growth opportunities for the Group
Attracting and developing world class talent
R&D Challenges: energy demand
IMPROVING SOLAR CELL EFFICIENCY DEMONSTRATING KEY TECHNOLOGIES FOR RENEWABLE ENERGY SECTOR DEVELOPING EFFICIENT INDUSTRIAL PROCESSES AND TECHNOLOGIES
Research & Development 14 2014 World leader in gases, technologies and services for Industry and Health
Paving the way to solar energy
Preferred gas and precursors supplier to 16 out of 20 of the largest crystalline silicon (c-Si) solar cell manufacturers worldwide
In-house R&D pilot line to produce c-Si solar cells - from wet cleaning to full cell characterization platform
Platform to speed-up development of next generation passivation layer to increase solar cell performance
Developing joint collaborations with industry leaders, OEMs* and academics
Partnership with IPVF, fostering open Innovation for next generation photovoltaic technologies
*Original Equipment Manufacturers
Research & Development 15 2014 World leader in gases, technologies and services for Industry and Health
Accelerating “Biomass to Liquids” (BtL) demonstration
Demonstration of 2nd Generation Biofuel process Bioliq together with KIT
Straw pyrolysis leading to synthetic crude oil with high energy density
Gasification to produce H2/CO
Transformation into diesel through catalytic process
Producing potential of 1liter of diesel from 7 kg of straw
Providing high quality products with low carbon footprint
Partnering with CEA* to develop a novel biomass gasification process
* Commission for atomic energy and alternative energies in France
Research & Development 16 2014 World leader in gases, technologies and services for Industry and Health
Securing Air Liquide plant competitiveness
eal Time Optimization (RTO) is an automatic and on-line mode dedicated to ASU operations. 4% of energy cost reduction has already been obtained on ASUs where RTO has been implemented.
2 major drivers for Air Separation Unit improvement:
Design: Process scheme to minimize energy consumption, and optimize equipment design (performance improvement and capex reduction)
Operations: using on-line simulators to perform 24/7 automatic optimization (Real Time Optimization)
R
EXPERT SPEAKING
Thanos Kontopoulos Global Lab Director
Research & Development 17 2014 World leader in gases, technologies and services for Industry and Health
Raising standards towards offshore industry
Providing autonomy and space optimization through high-pressure cylinder quads for welding and diving applications
Ensuring compliance with customer and regulatory requirements such as international maritime standards - DNV2.7-1
Improving welding quality and productivity with Argon based mixtures for metallic offshore structures and pipelines
Meeting increasing demand with 75,000 km of pipeline planned for 2020
International Marine Contractors Association
R&D Challenges: bio-economy & eco-design
IMPROVING ECONOMICS OF THE ENTIRE H2E CHAIN
REDUCING INDUSTRIAL EMISSIONS VIA OXYCOMBUSTION
ADDRESSING NEW REQUIREMENTS FOR WASTE WATER TREATMENT
Research & Development 19 2014 World leader in gases, technologies and services for Industry and Health
Towards a H2 economy
Producing, by 2020, 50% of H2 for energy applications through carbon-free processes: CCS, biogas reforming, biomass gasification, renewable energies
Developing advanced H2 storage solutions for safe and efficient delivery: gaseous (700 bar) and solid
Supporting fuel cell development: improved components and H2 quality for higher performance
Leading pre-normative research for safe H2: understanding H2 behavior, risk assessment tools and mitigation solution design, testing methods
Promoting societal acceptance of H2 as energy vector
Research & Development 20 2014 World leader in gases, technologies and services for Industry and Health
Producing a competitive clean power
ur 1st objective is to validate near zero CO2 emission at a coal oxyfuel power plant at industrial scale, eventually contributing to the creation of the FutureGen 2.0 plant in the US.
O
Callide oxyfuel project (Australia)
World’s first industrial scale demonstration of a near zero CO2 emission coal-fired power plant with carbon capture and storage
Air Liquide provides oxygen, Cryocap ™ Oxy unit (CO2 compression and purification) and analyzers (monitoring and product quality)
EXPERT SPEAKING
Jean-Pierre Tranier, Program Director
Research & Development 21 2014 World leader in gases, technologies and services for Industry and Health
Innovating for eco-friendly cold transportation
&D contributed to develop reliable and easy-to-operate on board truck equipment meeting the most challenging needs for refrigerated transport, especially in urban operating conditions
A comprehensive cryogenic solution based on indirect cooling with liquid nitrogen
On board cooling equipment, supply station and services
R
EXPERT SPEAKING
Linda Myrick Program Director
Research & Development 22 2014 World leader in gases, technologies and services for Industry and Health
Partnering with best-in-class academics
Québec University, Trois Rivières (Canada) Reduce cost of hydrogen transportation, purification, storage and distribution technologies with Hydrogen Research Institute - 2010
Kyushu University, Fukuoka (Japan) Research on materials to accelerate full realization of Hydrogen Energy society with Hydrogenius Center – 2010
Mines Paris-Tech (France) First industrial Chair to reduce CO2 emissions with engineering school Mines Paris Tech and city of Le Havre - 2009
École Centrale Paris (France) Educational and research chair on oxycombustion with Ecole Centrale Paris, CNRS, funded by ANR, French National Research Agency – 2012
R&D Challenges: health & wellness
DEMONSTRATING SAFETY, EFFICACY AND BENEFITS OF GASEOUS DRUGS CREATING NEW HOME HEALTHCARE SERVICES FOR PATIENTS DEVELOPING MEDICAL EQUIPMENT AND DEVICES FOR INTEGRATED VALUE-ADDED OFFERS
Research & Development 24 2014 World leader in gases, technologies and services for Industry and Health
Extending therapeutic gases potential
EXPERT SPEAKING
Marc Lemaire
Senior Medical Advisor
M arket access requires significant investment in R&D. Our mission is to understand mechanisms of action and demonstrate benefits of gas molecules such as oxygen, helium oxygen, argon, nitrous oxide, xenon.
New indications for therapeutic gases
7 to 12 years, from research to market
Major ongoing clinical trials
New gaseous drugs available for: Cardiac surgery
Analgesia
Pulmonary diseases
Research & Development 25 2014 World leader in gases, technologies and services for Industry and Health
Neurodegenerative and demyelinating diseases (Alzheimer’s, Parkinson’s..)
Explore noble gases mechanisms of action on neuron protection and cell preservation
Partnership with ICM
Parkinson’s disease
Evaluate effects of xenon on L-Dopamine-induced dyskinesia
Experiments performed at MOTAC Neurosciences, UK
Research in Central Nervous System disorders
Research & Development 26 2014 World leader in gases, technologies and services for Industry and Health
Excelling in home healthcare services
Chronic Obstructive Pulmonary Disease * COPD on Oxygen patient Management European Trial
Oxygen therapy for COPD: ongoing European clinical trial – COMET* – improving patients’ health and quality of life, reducing hospitalization rate through:
Patient education and coaching
Oxygen therapy monitoring using a specific device - NOWOX™
Treatment coordination between city and hospital (telemonitoring)
More than 300 patients in 4 countries
Sleep apnea: NOWAPITM
Development of a telemedecine solution to monitor patient compliance (France)
Largest telemonitoring experience in the world with 150 000 patients equipped by mid-2014
Research & Development 27 2014 World leader in gases, technologies and services for Industry and Health
First cylinder speaking the customer language:
Gives users the remaining treatment time (in hours and minutes) according to the set flow when the cylinder is in use
Development by R&D and ALMS of the digital device to define treatment time
User benefits:
Safety: secure patient treatment continuity thanks to straight forward information and low content alerts
Easy to use: new ergonomic cap and integrated valve
Efficiency: intelligible and straight forward information (remaining treatment time) allows accurate consumption management
Implemented in 12 countries
TAKEO™ : proposing new technologies for treatment management
R&D Challenges: digital & direct
ADVANCED PRECURSORS FOR MORE EFFICIENT CHIPS MOLECULES FOR ADVANCED THIN FILMS DEPOSITION CUSTOMIZED DELIVERY SYSTEMS FOR SEMICONDUCTOR INDUSTRY
Research & Development 29 2014 World leader in gases, technologies and services for Industry and Health
Winning the Moore’s law challenge
Meet customers’ needs: lower resistivity materials, better insulators and more thermal resistance
Invent new advanced precursors and added-value molecules deposited on materials surface for thin film creation
In-house core competencies and demonstrators to develop and test materials
Highly engineered precursors – “R&D designed” - currently ramping up on the market: ZyALDTM, SAM 24TM…
Develop joint collaborations with industry leaders, OEMs* and academics
*Original Equipment Manufacturers
Research & Development 30 2014 World leader in gases, technologies and services for Industry and Health
Partnering with best-in-class academics
New advanced precursors for ALOHATM
product line: conception, characterization and evaluation of organo-metallic molecules for thin film deposition
New Electronic Specialty Gases for reactor cleaning and etching of advanced materials
Research & Development 31 2014 World leader in gases, technologies and services for Industry and Health
Adapting to new mobile uses
Gas Encyclopedia app on tablets
64 molecules: chemical and physical properties, industrial applications and safety data
Addressing a worldwide technical and scientific audience in industry and academics, including our customers, teachers, students…
Air Liquide expertise condensed in a digital technology offering numerous new functionalities: 3D molecules, unit converter wheel, molecule comparison tool…
R&D Challenges: local innovation
ACCOMPANYING THE GROWTH OF DEVELOPING ECONOMIES DEVELOPING LOCAL AND FRUGAL INNOVATION ADDRESSING THE CHALLENGES OF MEGA-CITIES
Research & Development 33 2014 World leader in gases, technologies and services for Industry and Health
Delivering competitive technologies for the Chinese market
y integrating new developments into a mature process we could reduce the total cost of ownership by 30%.
Rectisol® technology
Single step process to purify syngas (from coal, oil, biomass) to synthesis quality
Mature process with 80% market share in purification of syngas from coal and oil gasification and 60 years successful commercial applications
Continuous process optimization serving dedicated needs of Chinese coal to chemicals / fuels industry
B EXPERT SPEAKING
Holger Schlichting, Program Director
Research & Development 34 2014 World leader in gases, technologies and services for Industry and Health
Capturing new academic opportunities
China: Joint Lab with Zheijang University Solid fuel oxy-combustion technology development for customers in developing countries
China: Strategic R&D agreement with Shanghai Jiao Tong University
Industrial solutions for manufacturing and semiconductor industries
South Korea: Joint Lab with Yonsei University
New advanced materials design, in collaboration with top-tier academic and industry partners
Better impact on industry ecosystem thanks to proximity with customers
Shanghai Jiao Tong University partnership
Research & Development 36 2014 World leader in gases, technologies and services for Industry and Health
Air Liquide laboratory for new ideas
Identify & select new battlefields
Support Group strategy
Try quickly, fail early, succeed big
Learning by doing
Think Tank
Transform uncertainties into opportunities
Corporate Garage
Turn ideas into business
Research & Development 37 2014 World leader in gases, technologies and services for Industry and Health
Create long-term value : explore new territories
Brief 1: Additive Manufacturing Brief 2: High-performance cities Brief 3: Digitalization and connected citizen …
New Uses = New Value Chains MULTIDISCIPLINARY TEAM
Result-driven,Visionary, Agile to
open new ways
Creating added value for our customers
Leading global innovation ecosystem
Addressing society’s
future challenges